Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice.
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Should MRI be the primary endpoint of phase 3 trials in multiple sclerosis?
[Thoughts on hot issues of neuromyelitis optica].
Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.
Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis.
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.
Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis.
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.
Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis.
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.
Tumefactive multiple sclerosis requiring emergency craniotomy: Case report and literature review.
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
Comparison of Vitamin D3 Serum Levels in New Diagnosed Patients with Multiple Sclerosis versus Their Healthy Relatives.
MRI lesions: a surrogate for relapses in multiple sclerosis?
[Contribution of cerebral magnetic resonance imaging to etiological investigation of uveitis.]
An initial top-down proteomic analysis of the standard cuprizone mouse model of multiple sclerosis.
High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cells.
Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues.
The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system.
Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosis.
Clinical characteristics of intermediate uveitis in adult Turkish patients.
Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction.
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care.
Pages
« first
‹ previous
…
596
597
598
599
600
601
602
603
604
…
next ›
last »